drugset / Trial / NCT03490019
Treatment of Bardet-Biedl-Syndrome With Metformin for Evaluation of a Possible Visual Improvement
NaSingle-groupOpen-labelTreatment
Summary
In this prospective pilot study without control group children and young adults (10-25 years old) diagnosed with Bardet-Biedl syndrome and treated with Metformin for their adipositas will be evaluated for a possible additional effect of Metformin on visual acuity.
Timeline
- Start
- 2018-04-01
- Primary completion
- 2019-10
- Completion
- 2020-08
Outcome
Outcome not reported
Stopped: “unrealizable wishes of national authorities”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Metformin | Small molecule | 500 mg | — |
| Subject | Metformin | Small molecule | 850 mg | — |
| Subject | Metformin | Small molecule | 1000 mg | — |